Intrinsically vancomycin-resistant Gram-positive organisms: Clinical relevance and implications for infection control

Journal of Hospital Infection

Volumn 42, Issue 4, 1999, Pages 275-282

  Nelson, R R S ^a  

^a WESTERN INFIRMARY   (United Kingdom)

Author keywords

Enterococcus; Erysipelothrix; Intrinsic resistance; Lactobacillus; Leuconostoc; Pediococcus; Vancomycin

Indexed keywords

BETA LACTAM ANTIBIOTIC; CHLORAMPHENICOL; CLINDAMYCIN; GENTAMICIN; GLYCOPEPTIDE; IMIPENEM; QUINOLINE DERIVED ANTIINFECTIVE AGENT; TEICOPLANIN; VANCOMYCIN;

ANTIBIOTIC RESISTANCE; BACTERIAL GENE; BACTERIAL INFECTION; BACTERIUM IDENTIFICATION; ENTEROCOCCUS; ERYSIPELOTHRIX; GENETIC RESISTANCE; GRAM POSITIVE BACTERIUM; HUMAN; INFECTION CONTROL; LACTOBACILLUS; LEUCONOSTOC; NONHUMAN; PEDIOCOCCUS; REVIEW;

EID: 0032806503     PISSN: 01956701     EISSN: None     Source Type: Journal    
DOI: 10.1053/jhin.1998.0605     Document Type: Review

References (70)

1. LeClerq R. H., Derlot E., Duval J., Courvalin P. Plasmid mediated resistance to vancomycin and teicoplanin Enterococcus faecium. New England Journal of Medicine. 319:1988;157-161.
2. Uttley A. H. C., Collins C. H., Naidoo J., George R. C. Vancomycin-resistant enterococci. Lancet. 1:1988;57-58.
3. Infect Control Hosp Epidemiology. 16:1995;105-113.
4. Bowler I. C. J., Storr J. A., Davies G. L., Crook D. W. M. Guidelines for the management of patients colonised or infected with vancomycin-resistant enterococci. J Hosp Infect. 39:1998;75-76.
5. Clark N. C., Teixeira L., Facklam R., Tenover F. C. Detection and differentiation of vanC-1, vanC-2 and vanC-3 glycopeptide resistance genes in enterococci. J Clin Microbiol. 36:1998;2294-2297.
6. Colins M. D., Jones D., Farrow J. A. E., Klipper-Balz R., Schliefer K. H. Enterococcus avium nom.rev., com.nov.;E.casseliflavus nom.rev., com.nov.;E. gallinarum. 34:1984;220-223.
7. Vincent S., Knight R. G., Green M., Sahm D. F., Shlaes D. M. Vancomycin susceptibility and identification of motile enterococci. J Clin Microbiol. 29:1991;2335-2337.
8. Dutka-malen S., Blaimont M., Wauters G., Courvalin P. Emergence of high-level resistance to glycopeptides in Enterococcus gallinarum and Enterococcus casseliflavus. Antimicrob Agents and Chemother. 38:1994;1675-1677.
9. Pompei R., Berlutti F., Thaller M. C., Ingianni A., Cortis G., Dainelli B. Enterococcus flavescens sp.nov., a new species of enterococcus of clinical origin. Int J Syst Bacteriol. 42:1992;365-369.
10. Navarro, F. Courvalin, P. Analysis of genes encoding D-Alanine-D-Alanine ligase related enzymes in Enterococcus casseliflavus andEnterococcus flavescens Antimicrob Agents Chemother 1994;38: 1788-1793.
11. Leclerq R., Dutka-malen S., Duval J., Courvalin P. Vancomycin resistance gene vanC is specific to Enterococcus gallinarum. Antimicrob Agents Chemother. 36:1992;2005-2008.
12. Vandamme P., Veracauteren E., Lammer S. C., Perisart N., Ieven M., Pot B., Leclerq R., Goosens H. Survey of enterococcal susceptibility patterns in Belgium. J Clin Microbiol. 34:1996;2573-2576.
13. Toye B., Shymanski J., Bobrowska M., Woods W., Ramotar K. Clinical and epidemiologic significance of Enterococci intrinsically resistant to vancomycin (possessing thevanC phenotype). J Clin Microbiol. 35:1997;3166-3170.
14. Patel R., Uhl J. R., Kohner P., Hopkins M. K., Cockerill F. R. Multiplex PCR detection of vanA, vanB, vanC-1 and vanC-2/3 genes in enterococci. J Clin Microbiol. 35:1997;703-707.
15. Patel R., Piper K. E., Rouse M. S. Determination of 16s RNA sequences of enterococci and application to species indentification of non-motileEnterococcus gallinarum isolates. J Clin Microbiol. 36:1998;3399-3407.
16. Dutka-malen S., Evers P., Courvalin P. Detection of glycopeptide resistance genotypes and identification to species level of clinically relevant enterococci by PCR. J Clin Microbiol. 33:1995;24-27.
17. Reynolds, P. E. Snaith, H. A. Maguire, A. J. Dutka-malen, S. Courvalin, P. Analysis of peptidoglycan precursors in vancomycin-resistant Enterococcus gallinarum Biochemical Journal 1994;301: 5-8.
18. Sahm D. F., Free L., Handwerger S. Inducible and constitutive expression of vanC-1 encoded resistance to vancomycin in Enterococcus gallinarum. Antimicrob. Agents and Chemother. 39:1995;1480-1484.
19. Arthur M., Reynolds P. E., Depardieu F. Mechanisms of glycopetide resistance in enterococci. J Infect. 32:1996;11-16.
20. Facklam R. R., Collins M. D. Identification of Enterococcus species isolated from human infections by a conventional test scheme. J Clin Microbiol. 27:1989;731-734.
21. Cartwright C. P., Stock F., Fahle G. A., Gill V. J. Comparison of pigment production and motility tests with PCR for reliable identification of intrinsically vancomycin-resistant enterococci. J Clin Microbiol. 33:1995;1931-1933.
22. Gordts B., Van landuyt H., Ieven M., Vandamme P., Goossens H. Vancomycin-resistant enterococci colonising the intestinal tract of hospitalised patients. J Clin Microbiol. 33:1995;2842-2846.
23. Turenne, C. Y. Hoban, D. J. Karlowsky, J. A. Zhanel, G. G. Kabani, A. M. Screening of stool samples for identification of vancomycin-resistant Enterococcus isolates should include the methyl-alpha-D-glucopyranoside test to differentiate non-motile Enterococcus gallinarum from Enterococcus faecium J Clin Microbiol 1998;36: 2333-2335.
24. Da Gloria M., Carvalho S., Teixeira L. M., Facklam R. R. Use of tests of acidification of methyl-alpha-D-glucopyranoside and susceptibility to efrotomycin for differentiation of strains of Enterococcus and some related genera. J Clin Microbiol. 36:1998;1584-1587.
25. Liassine N., Frei R., Jan I., Auckenthaler R. Characterisation of glycopeptide-resistant enterococci in a Swiss hospital. J Clin Microbiol. 36:1998;1853-1858.
26. Boisivon A., Thibault M., Leclerq R. Colonisation of vancomycin-resistant enterococci of the intestinal tract of patients in intensive care units from French general hospitals. Clin Microbiol Infect. 3:1997;175-179.
27. Gopal Rao G., Ojo F., Kolokithas D. Vancomycin-resistant Gram-positive cocci: risk factors for faecal carriage. J Hosp Infect. 35:1997;63-69.
28. Blaimont B., Charlier J., Wauters G. Comparative distribution of Enterococcus species in faeces and clinical samples. Microb Ecol Health Dis. 8:1995;87-92.
29. Van Horn K. G., Rodney K. M. Colonisation and microbiology of the motile enterococci in a patient population. Diagnostic microbiology and Infectious Disease. 31:1998;525-530.
30. Nelson R. R. S. Selective isolation of vancomycin-resistant enterococci. J Hosp Infect. 39:1998;13-18.
31. Perlada D. E., Smulian A. G., Cushion M. T. Molecular epidemiology and antibiotic susceptibility of enterococci in Cincinnati, Ohio: a prospective city-wide survey. J Clin Microbiol. 35:1997;2342-2347.
32. Ruoff K. L., De la Maza L., Murtagh M., Spargo J. D., Ferraro M. J. Species identities of enterococci isolated from clinical specimens. J Clin Microbiol. 28:1990;435-437.
33. Van Belkum A., Van der Braak N., Thomassen R., Verbrugh H., Endtz H. Vancomycin-resistant enterococci in dogs and cats. Lancet. 348:1996;1038-1039.
34. Van der Braak N., Van Belkum A., Van Keulen M., Vliegenthart J., Verbrugh H. A., Endtz H. P. Molecular characterisation of vancomycin-resistant enterococci from hospitalised patients and poultry products in the Netherlands. J Clin Microbiol. 36:1998;1927-1932.
35. Boyce J. M., Opal S. M., Chow J. W. Outbreak of multi-drug resistant Enterococcus faecium with transferable vanB class vancomycin resistance. J Clin Microbiol. 32:1994;1148-1153.
36. Fantain B., Leclerq R., Arthur M., Duval J., Carbon C. Influence of low-level resistance to vancomycin on efficacy of teicoplanin and vancomycin for treatment of experimental endocarditis due to Enterococcus faecium. Antimicrob Agents Chemother. 35:1991;1570-1575.
37. Kaplan A. H., Gilligan D. H., Facklam R. R. Recovery of resistant enterococci during vancomycin prophylaxis. J Clin Microbiol. 26:1988;1216-1218.
38. Sahm D. F., Free L., Smith C., Eveland M., Mundy L. H. Rapid characterisation schemes for surveillance isolates of vancomycin-resistant enterococci. J Clin Microbiol. 35:1997;2020-2024.
39. Gordon S., Swenson J. A., Hill B. C. Antimicrobial susceptibility patterns of common and unusual species of enterococci causing infection in the United States. J Clin Microbiol. 30:1992;2373-2378.
40. Power E. G. M., Abdullah Y. H., Tabania H. G., Spice W., Aathithan S., French G. L. vanA genes in vancomycin-resistant clinical isolates of Oerskovia turbata and Arcanobacterium (Corynebacterium) haemolyticum. J Hosp Infect. 36:1995;595-606.
41. Poyart C., Pierre C., Quesne G., Pron B., Berche P., Triev-cuot P. Emergence of vancomycin resistance in the genus Streptococcus: characterisation of a vanB transferable determinant in Streptococcus bovis. Antimicrob Agents Chemother. 41:1997;24-29.
42. Van Horn K. G., Gedris C. A., Rodney K. M. Selective isolation of vancomycin-resistant enterococci. J Clin Microbiol. 34:1996;924-927.
43. Johnson A. P., Uttley A. H., Woodford N., George R. C. Resistance to vancomycin and teicoplanin: an emerging clinical problem. Clin Microbiol Rev. 3:1990;280-291.
44. Felmingham D., O'Grady F., Lambert H. P., Finch R. G., Greenwood D. Glycopeptides. Antibiotics and Chemotherapy, 7th. edn. 1997;Edinburgh, Churchill Livingstone. p. 363-368.
45. Billot-Klein D., Gutman L., Sable S., Guittet E., Van Heijenoort J. Modification of the peptidoglycan precursors is a common feature of low-level vancomycin-resistant VanB type enterococcus D366 and of the naturally glycopeptide-resistant species Lactobacillus casei, Pediococcus pentosaceus, Leuconostoc mesenteroides and Enterococcus gallinarum. J Bacteriol. 176:1994;2398-2405.
46. Handwerger S., Pucci MJ Volk K. J., Liu J., Less M. S. Vancomycin-resistant Leuconostoc mesenteroides and Lactobacillus casei synthesise cytoplasmic peptidoglycan precursors that terminate in lactate. J Bacteriol. 176:1994;260-264.
47. Ruoff, K. L. Leuconostoc, Pediococcus, Stomatococcus and miscellaneous Gram-positive cocci that grow aerobically. Murray PR Baron, E. J. Pfaller, M. A. Tenover, F. C. Yolken, R. H. Manual of Clinical Microbiology, 6th edn, ASM Press, Washington DC 1995, 315-323.
48. Clarridge, J. E. Spiegel, C. A. Corynebacterium and miscellaneous irregular Gram-positive rods, Erysipelothrix andGardnerella. Murray PR Baron, E. J. Pfaller, M. A. Tenover, F. C. Yolken, R. H. Manual of Clinical Microbiology, 6th edn, ASM Press, Washington DC 1995, 357-378.
49. Hillier, S. L. Moncla, B. J. Peptostreptococcus, Propionobacterium, Eubacterium and other non-sporeforming anaerobic Gram-positive bacteria. Murray PR Baron, E. J. Pfaller, M. A. Tenover, F. C. Yolken, R. H. Manual of Clinical Microbiology, 6th edn, ASM Press, Washington DC 1995, 587-602.
50. Facklam, R. R. Sahm, D. F. Entercoccus, Murray PR Baron, E. J. Pfaller, M. A. Tenover, F. C. Yolken, R. H. Manual of Clinical Microbiology, 6th edn, ASM Press, Washington DC 1995, 308-314.
51. Vazquez E., Carazo I., Martin A., Lozano C., Cuesta I., Pagola C. Infective endocarditis due to Leuconostoc mesenteroides. Enfermedades Infecciosas y Microbiologica Clinica. 16:1998;237-238.
52. Espinoza R., Kusne S., Pasculle A. W., Wada S., Fung J., Rakela J. Leuconostoc bacteremia after liver transplantation: another cause of vancomycin-resistant Gram-positive infection. Clinical Transplantation. 11:1997;322-324.
53. Dhodapkar K. M., Henry N. K. Leuconostoc bacteremia in an infant with short-gut syndrome: case report and literature review. Mayo Clinic Proceedings. 71:1996;1171-1174.
54. Borer A., Weber G., Solling Avnon L., Riesenberg K., Alkan M. Pleural empyema caused by Leuconostoc spp. Scandanavian Journal of Infectious Diseases. 29:1997;311-312.
55. Ferrer S., De Miguel G., Domingo P., Pericas R., Prats G. Pulmonary infection due to Leuconostoc species in a patient with AIDS. Clin Infect Dis. 21:1995;225-226.
56. Davis A. J., James P. A., Hawkey P. M. Lactobacillus endocarditis. J Infect. 12:1986;169-174.
57. Lorenz R. P., Appelbaum P. C., Ward R. M., Botti J. T. Chorioamniotitis and possible neonatal infection associated with Lactobacillus species. J Clin Microbiol. 16:1982;558-561.
58. Bayer A. S., Chow A. W., Betts D., Guze L. B. Lactobacillemia - report of nine cases. Important clinical and therapeutic considerations. Am J Med. 64:1978;808-813.
59. Namnyak S. S., Blair A. L. T., Hughes D. F., McElhinney P., Donnelly M. R., Corey J. Fatal lung abscess due to Lactobacillus casei ss. rhamnosus. Thorax. 47:1992;666-667.
60. Mastro T. D., Spika J. S., Lozano P., Appel J., Facklam R. R. Vancomycin-resistant Pediococcus acidilactici: nine cases of bacteremia. J Infect Disease. 161:1990;956-960.
61. Golledge C. L., Stingemone N., Ararena M., Joske D. Septicemia caused by vancomycin-resistant Pediococcus acidilactici. J Clin Microbiol. 28:1990;1678-1679.
62. Sarma P. S., Mohanty S. Pediococcus acidilactici pneumonitis and bacteraemia in a pregnant woman. J Clin Microbiol. 36:1998;2392-2393.
63. Corcoran G. D., Gibbons N., Mulvihill T. E. Septicemia caused by Pediococcus pentosaceus: a new opportunistic pathogen. J Infect. 23:1991;179-182.
64. Erlich J. C. Erysipelothrix rhusiopathiae infection in man. Arch Int Med. 78:1946;565-577.
65. Gorby G. L., Peacock J. E. Erysipelothrix rhusiopathiae endocarditis: microbiologic, epidemiologic and clinical features of an occupational disease. Rev Infect Dis. 10:1988;317-325.
66. Ognibene F. D., Cunnion R. E., Gill V. Erysipelothrix rhusiopathiae bacteremia presenting as septic shock. Am J Med. 78:1985;861-864.
67. Schuster M. G., Brennan P. J., Edelstein P. Persistent bacteremia with Erysipelothrix rhusiopathiae in a hospitalised patient. Clin Infect Dis. 17:1993;783-784.
68. Swenson J. M., Facklam R. R., Thornsberry C. Antimicrobial susceptibility of vancomycin-resistant Leuconostoc, Pediococcus and Lactobacillus species. J Clin Microbiol. 30:1992;2373-2378.
69. Venditti M., Gelfusa V., Tarasi A. Antimicrobial susceptibilities of Erysipelothrix rhusiopathiae. Antimicrob Agents Chemother. 34:1990;2038-2040.
70. Sanyal D., Williams A. J., Johnson A. P., George R. C. The emergence of vancomycin resistance in renal dialysis. J Hosp Infect. 24:1993;167-172.